Name: | Description: | Size: | Format: | |
---|---|---|---|---|
93.8 KB | Adobe PDF |
Advisor(s)
Abstract(s)
In this work we explored the role of the 3'UTR of the MECP2 gene in patients with clinical diagnosis of RTT and mental retardation; focusing on regions of the 3'UTR with almost 100% conservation at the nucleotide level among mouse and human. By mutation scanning (DOVAM-S technique) the MECP2 3'UTR of a total of 66 affected females were studied. Five3'UTR variants in the MECP2 were found (c.1461+9G>A, c.1461+98insA, c.2595G>A, c.9961C>G and c.9964delC) in our group of patients. None of the variants found is located in putative protein-binding sites nor predicted to have a pathogenic role. Our data suggest that mutations in this region do not account for a large proportion of the RTT cases without a genetic explanation.
Description
Keywords
3' Untranslated Regions/genetics Intellectual Disability/genetics Methyl-CpG-Binding Protein 2/genetics Rett Syndrome/genetics Genetic Variation Genotype Methyl-CpG-Binding Methyl-CpG-Binding Protein 2/metabolism Mutation Phenotype Polymerase Chain Reaction Female HDE NEU PED
Citation
Dis Markers. 2008; 24 (6):319-24.